Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis
Open Access
- 11 May 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 15 (11) , 2027-2038
Abstract
Heterozygous loss-of-function mutations in the tumour necrosis factor alpha induced protein 3 (TNFAIP3) gene cause an early-onset auto-inflammatory disease named haploinsufficiency of A20 (HA20). Here we describe three unrelated patients with autoimmune lupus nephritis (LN) phenotypes carrying three novel mutations in the TNFAIP3 gene. Whole-exome sequencing (WES) was used to identify the causative mutations in three biopsy-proven LN patients. Sanger sequencing and quantitative polymerase chain reaction (qPCR) were used to validate the mutations identified by WES. RNA sequencing, qPCR and cytometric bead array was used to detect inflammatory signatures in the patients. The patients predominantly presented with an autoimmune phenotype, including autoimmune haemolytic anaemia, multipositive autoantibodies and LN. Additionally, novel phenotypes of allergy and pericardial effusion were first reported. WES identified three novel heterozygous mutations in the TNFAIP3 gene, including a novel splicing mutation located in the canonical splicing site (c.634+2T>C) resulting in an intron 4 insertion containing a premature stop codon, a de novo novel copy number variation (exon 7–8 deletion) and a novel nonsense mutation c.1300_1301delinsTA causing a premature stop codon. We further identified hyperactivation signatures of nuclear factor- kappa B and type I IFN signalling and overproduction of pro-inflammatory cytokines in the blood. This report expanded the phenotype to a later age, as two girls were diagnosed at age 3 years and one man at age 29 years. Kidney involvement may be the main feature of the clinical spectrum of HA20, even in adults. Genetic screening should be considered for early-onset LN patients.Keywords
Funding Information
- National Natural Science Foundation of China (32141004, 82170739)
- Jiangsu Biobank of Clinical Resources (BM2015004-1)
- Jiangsu Biobank of Clinical Resources (JSRB2021-02)
This publication has 44 references indexed in Scilit:
- Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in AsiansThe American Journal of Human Genetics, 2013
- Type I Interferon and Systemic Lupus ErythematosusJournal of Interferon & Cytokine Research, 2011
- Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritisNature Immunology, 2011
- The Ubiquitin-Editing Protein A20 Prevents Dendritic Cell Activation, Recognition of Apoptotic Cells, and Systemic AutoimmunityImmunity, 2011
- B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged miceBlood, 2011
- The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents AutoimmunityImmunity, 2010
- Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor–induced toxicity and experimental colitisJournal of Experimental Medicine, 2010
- Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosusNature Genetics, 2009
- A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusNature Genetics, 2009
- Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosusNature Genetics, 2008